SA artist Sjava wins big at BET Awards
She dedicated the award to those "lost in the world", saying: "Follow your passion. believe in yourself". Drake is also a double nominee for video of the year with "God's Plan" and "Walk It Talk It" with Migos.

Three things we learned today at the World Cup
Tunisia will square off with Panama on Thursday, but could be eliminated by then, should England draw with Panama on Sunday. The versatile star is a field general for South Korea, thanks to his defensive prowess and offensive instincts.

Messi to have more ball time against Nigeria
Messi, who turned 31 on Sunday, could be making his final World Cup appearance if Argentina fail to progress. Argentina clinched Group F's top spot while Nigeria claimed second in this memorable Brazil 2014 encounter.

Portugal Team, Predicted Playing XI vs Iran
Iran vs Portugal match will be played on June 25, Monday, at Mordovia Arena and it will start from 11:30 pm India time . The European champions were camped in the Iran half for most of the second half as they pushed for a second goal .

Mavs swap picks with Hawks to get Luka Doncic
It appears the Dallas Mavericks will prioritze rest for their prized rookie, who is coming off a long EuroLeague season. The reigning Associated Press player of the year averaged 18.9 points and 4.6 assists in his final season.

The medicinal acknowledgment of CBD should come as good news to marijuana startups eyeing the compound for consumer and medical consumption. The chemical's use in seizure prevention is well-documented in reputable research, and now, after conducting its own trials, the FDA is on board.

Although THC can induce paranoia, anxiety and hallucinations, CBD has the opposite effect and has been cited by scientists as a potential treatment for mental health issues. "Yet we were surprised at how robust the response was in this study", Dr. Anup Patel, a pediatric neurologist at Nationwide Children's Hospital in OH and one of the lead authors of the study, told ABC News.

At time of publication, GW Pharma shares had receded to trade down 1.7 percent on the day - a potential case of "buying the rumor, selling the news" considering GW's pre-approval run.

A doctor talks to a patient in this undated stock photo. "In addition to another important treatment option for Lennox-Gastaut patients, this first-ever approval of a drug specifically for Dravet patients will provide a significant and needed improvement in the therapeutic approach to caring for people with this condition". Dravet Syndrome is confirmed with a genetic test.

"While these areas are at an earlier stage of development, the evidence we have, it's very much a science-led program", Gover said.

Dr. Nicholas Chadi, a pediatrician completing his fellowship at Boston Children's Hospital in pediatric and adolescent addictions, points to the limited research on CBD side effects in general.

Cannabidiol is one of more than 80 active cannabinoid chemicals, yet unlike tetrahydrocannabinol, or THC, it does not produce a high. It may also have far-reaching implications for USA marijuana policy. "Because of the adequate and well-controlled clinical studies that supported this approval, prescribers can have confidence in the drug's uniform strength and consistent delivery". The agency is expected to do so within 90 days. British drugmaker GW Pharmaceuticals expects the oral solution to hit the market this fall.

What should parents be aware of now? The FDA is willing to help companies that want to pursue such research programs, he said, but they need to prove their products work and are safe with data from clinical trials.

Most patients with LGS and DS require multiple seizure medications and the majority are resistant to now approved anti-epileptic drugs.

In Ohio, a bill in the Senate would remove drug schedules from state law and instead have the state pharmacy board schedule substances in rules and regulations. "They may also be contaminated with other things, so the safety, particularly for children, is concerning", Patel told ABC News.

It's an option for those patients who have not responded to other treatments to control seizures.